Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 497 results for "ranbaxy laboratories"

Lifeline ends for Ranbaxy after half-a-century existence
DNA India

Lifeline ends for Ranbaxy after half-a-century existence

Search Ranbaxy Laboratories on the Google and the website link will take you to the Sun Pharmaceutical Industries official web page, as the Gurgaon-based Indian multinational giant has ceased to exist. There is no more official web page of Ranbaxy ... DNA India, 1 week ago

82 images for ranbaxy laboratories

Deccan Chronicle, 3 weeks ago, 1 week ago
Financial Express, 3 weeks ago
India Infoline, 1 month ago
Money Today, 3 weeks ago
Calcutta Telegraph, 3 weeks ago
Lawyer Herald, 1 month ago
First, 3 weeks ago
Financial Express, 1 month ago
IndiaVision, 1 month ago

Ranbaxy's stock market stint

Ranbaxy Laboratories was started in 1937 as a small medicine-distribution business in Amritsar by Ranjit Singh and Gurbax Singh. In 1952, Bhai Mohan Singh became the promoter of the company. The firm was officially incorporated in 1961 and went ...
 Livemint.com1 week ago

Ranbaxy Laboratories updates on scheme of arrangement

This page uses frames, but your browser doesn't
 Capital Market3 weeks ago Emcure to buy divested assets of Sun Pharma and Ranbaxy  Livemint.com3 weeks ago Pharmaceutical Newsletter - March 16 to 20, 2015  India Infoline1 month ago Ranbaxy, Sun Pharma at new high on HC nod for merger plan  Money Control1 month ago
The Telegraph

Seal on drug deal

The High Court of Punjab and Haryana today cleared the $4-billion merger of Ranbaxy Laboratories with Sun Pharma, bringing the deal to a close. The news saw stocks of both the companies hitting new highs on the bourses. The Sun Pharma stock touched Rs 1,049 ...
 The Telegraph1 month ago Sun-Ranbaxy merger clears last hurdle  Business Standard India1 month ago Decks cleared for Sun-Ranbaxy merger  DNA India1 month ago Sun-Ranbaxy merger clears final hurdle  Smart Investor1 month ago
Business Today India

Ranbaxy stock to stop trading on exchanges from next week

Pic Courtesy: - Zee Media BureauShares of Ranbaxy Laboratories will stop trading on BSE and NSE with effect from Monday (April 6) onwards as the company is merging with Sun Pharmaceutical Industries in a USD 4 billion deal. Sun Pharma would be ...
 ZeeNews.com2 weeks ago Ranbaxy: April 1 set as last day for trading  Hindu Business Line3 weeks ago Ranbaxy Shares to Stop Trading on Exchanges From April 6  New Indian Express3 weeks ago Ranbaxy Shares to Stop Trading on Bourses From April 6  NDTV Profit3 weeks ago
Med India

Sun Pharma Announces Closure of Merger Deal With Ranbaxy

Sun Pharmaceutical Industries Ltd has completed the (Dollar) 3.2 billion acquisition of Ranbaxy Laboratories Ltd on Wednesday. This merger will make Sun Pharma the largest pharmaceutical company in India with a market share of 9.2% and sales of (Dollar) 1.1 ...
 Med India3 weeks ago Sun Pharma completes Ranbaxy merger deal, Ranbaxy shares to be delisted  PharmaBiz3 weeks ago Sun Pharma brings to closure Ranbaxy merger  Prokerala3 weeks ago Sun Pharma, Ranbaxy merger finalized, a year after announcement  India TV3 weeks ago
NDTV Profit

Sun-Ranbaxy deal gets final CCI nod; Emcure to buy 7 brands

New Delhi: The Competition Commission of India (CCI) has given final clearance to Sun Pharmaceutical-Ranbaxy Laboratories merger, approving divestment of seven overlapping drugs of the two companies to Emcure Pharmaceuticals. The competition ...
 India Brand Equity Foundation3 weeks ago Sun-Ranbaxy gets CCI nod to sell 7 brands to Emcure  Times of India3 weeks ago Sun Pharma, Ranbaxy get CCI's nod to sell seven brands to Emcure Pharma  Indian-Commodity3 weeks ago Sun Pharma-Ranbaxy deal gets final CCI nod; Emcure to buy 7 brands  Financial Express3 weeks ago
DNA India

Sun Pharma readies new leadership

Taking forward its acquisition of Ranbaxy Laboratories, Sun Pharma has put in place a team of top executives, including Dilip Shanghvi’s son Aalok Shanghvi, to lead the businesses of both the organisations. While the leadership team is comprised mainly from ...
 Asian Age1 month ago Dilip Shanghvi's son Aalok to head emerging mkts unit after Sun Pharma buys Ranbaxy  VC Circle1 month ago Ranbaxy merger: Sun Pharma readies new leadership team  DNA India1 month ago Ranbaxy Acquisition: Sun Pharma Readies New Leadership Team  NDTV Profit1 month ago
Business Today India

Ranbaxy-Sun Pharma merger to create world's fifth-largest generic drug firm

With the merger of Ranbaxy Laboratories with Sun Pharma complete, India's richest entrepreneur Dilip Shanghvi has created the world's fifth-largest generic company after Teva, Sandoz, Mylan and Abbott. Ranbaxy Laboratories will cease to exit and ...
 Business Today India3 weeks ago Sun-Ranbaxy $4 bn deal: US anti-trust regulator FTC passes final order  Economic Times4 weeks ago FTC passes final order in USD 4 billion Sun-Ranbaxy deal  Money Control4 weeks ago Sun-Ranbaxy $4 billion deal: US anti-trust regulator FTC passes final order  Economic Times4 weeks ago
Business Standard

Sun Pharma, Ranbaxy gain ahead of merger

At 1107 hours, Sun Pharma and Ranbaxy Laboratories were up 3% each at Rs 1,052 and Rs 837 respectively. SI Reporter | Mumbai April 1, 2015 Last Updated at 11:11 IST Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories were trading higher by 3% ...
 Business Standard2 weeks ago Sun Pharma, Ranbaxy gain on closure of merger deal  Smart Investor3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy laboratories
Get updated on latest news & your favorite topics right in your inbox!
More     Less